Furthermore, according to Garrido et al. binding of nimotuzumab Fab fragments was detected only in the A431 cell line (106 receptors per cell), whereas cetuximab Fab fragments also bound to tumor cells with lower EGFR levels (40). The gene discussed is EGFR; the disease is neoplasm.